Ireland - English - HPRA (Health Products Regulatory Authority)

ranbaxy ireland limited - sertraline hydrochloride - film coated tablet - 50 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

ranbaxy ireland limited - sertraline hydrochloride - film coated tablet - 100 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

ranbaxy ireland limited - sertraline hydrochloride - film coated tablet - 50 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

ranbaxy ireland limited - sertraline hydrochloride - film coated tablet - 100 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

ranbaxy ireland limited - donepezil hydrochloride - film coated tablet - 5 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

ranbaxy ireland limited - donepezil hydrochloride - film coated tablet - 10 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

ranbaxy ireland limited - donepezil hydrochloride - film coated tablet - 5 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

ranbaxy ireland limited - donepezil hydrochloride - film coated tablet - 10 milligram

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - cefaclor monohydrate 267.5mg equivalent to cefaclor 250 mg (plus 2% overage);  ; cefaclor monohydrate 267.5mg equivalent to cefaclor 250 mg (plus 2% overage) - capsule - 250 mg - active: cefaclor monohydrate 267.5mg equivalent to cefaclor 250 mg (plus 2% overage)   excipient: brilliant blue fcf carmoisine colloidal silicon dioxide croscarmellose sodium gelatin   magnesium stearate methyl hydroxybenzoate   ponceau 4r pregelatinised maize starch propyl hydroxybenzoate   titanium dioxide   water   active: cefaclor monohydrate 267.5mg equivalent to cefaclor 250 mg (plus 2% overage) excipient: brilliant blue fcf carmoisine colloidal silicon dioxide croscarmellose sodium gelatin   magnesium stearate methyl hydroxybenzoate   ponceau 4r pregelatinised maize starch propyl hydroxybenzoate   titanium dioxide   - · lower respiratory infections, including pneumonia caused by s. pneumoniae, h. influenzae (including both ampicillin-sensitive and ampicillin-resistant strains), and s. pyogenes (group a beta- haemolytic streptococci), m.catarrhalis, acute bronchitis, and acute exacerbations of chronic bronchitis. · upper respiratory infections, including pharyngitis and tonsillitis caused by s. pyogenes (group a beta-haemolytic streptococci) and m. catarrhalis. note: penicillin is the usual medicine of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. amoxicillin has been recommended by the american heart association as the standard regimen for the prophylaxis of bacterial endocarditis for dental, oral, and upper respiratory tract procedures, with penicillin v a rational and acceptable alternative in the prophylaxis against beta-haemolytic streptococcal bacteriaemia in this setting. cefaclor is generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cefaclor in the subsequent prevention of rheumatic fever or bacterial endocarditis are not available at present.

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - cefaclor monohydrate 535mg equivalent to cefaclor 500 mg (plus 2% overage.) - capsule - 500 mg - active: cefaclor monohydrate 535mg equivalent to cefaclor 500 mg (plus 2% overage.) excipient: brilliant blue fcf carmoisine colloidal silicon dioxide croscarmellose sodium gelatin   iron oxide black magnesium stearate methyl hydroxybenzoate   ponceau 4r pregelatinised maize starch propyl hydroxybenzoate   titanium dioxide